Green Thumb Industries has submitted applications to the U.S. Drug Enforcement Administration (DEA) to register certain state-licensed medical cannabis operations under the expedited registration pathway created in connection with the recent rescheduling of medical marijuana to Schedule III of the Controlled Substances Act.
"Schedule III changes the future of medical cannabis in America, and Green Thumb is ready for what comes next," Green Thumb founder, Chairman and CEO Ben Kovler said. "Rescheduling recognizes what millions of patients have known for years, opens the door to more research and begins to fix the punitive tax treatment that has held responsible operators back. By seeking DEA registration, Green Thumb is taking a practical step toward a more normalized, regulated federal industry. We look forward to discussing this milestone along with our first quarter results with investors this Wednesday, May 6."
Green Thumb owns RISE Dispensaries across 14 U.S. markets and operates more than 110 retail locations serving both medical patients and adult-use consumers. The company manufactures and produces a leading and award-winning portfolio of branded products, including RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon's and Good Green.
Green Thumb will release its first quarter 2026 financial results after the market closes on May 6, 2026. A conference call and audio webcast will be held the same day at 5 p.m. Eastern Time / 4 p.m. Central Time to discuss results and answer questions.
For more information:
Green Thumb Industries
www.gtigrows.com
